Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Intensive Care Medicine
Published in: Intensive Care Medicine 10/2003

01-10-2003 | Original

Improved survival of critically ill cancer patients with septic shock

Authors: Jérôme Larché, Élie Azoulay, Fabienne Fieux, Laurent Mesnard, Delphine Moreau, Guillaume Thiery, Michaël Darmon, Jean-Roger Le Gall, Benoît Schlemmer

Published in: Intensive Care Medicine | Issue 10/2003

Login to get access

Abstract

Objective

To identify predictors of 30-day mortality in critically ill cancer patients with septic shock.

Design

Retrospective study over a 6-year period.

Setting

Twelve-bed medical intensive care unit (ICU).

Patients

Eighty-eight patients (55 men, 33 women) aged 55 (43.5–63) years admitted to the ICU for septic shock.

Interventions

None.

Measurements and main results

Eighty (90.9%) patients had hematological malignancies and eight (9.1%) had solid tumors; 47 patients (53.4%) were neutropenic, 19 (21.6%) were hematopoietic stem cell transplantation (HSCT) recipients, and 27 (30.7%) were in remission. Microbiologically documented infections were found in 60 (68.2%) patients. The Simplified Acute Physiologic Score II (SAPS II) and Logistic Organ Dysfunction (LOD) scores at ICU admission were 66 (47–89) and 7 (5–10), respectively, and the LOD score on day 3 was 8 (4–10). Sixty-eight (78.1%) patients received invasive mechanical ventilation (MV), 12 (13.6%) noninvasive MV, 22 (25%) dialysis. Thirty-day mortality was 65.5% (57/88). By multivariable analysis, mortality was higher when time to antibiotic treatment was >2 h [odds ratio (OR), 7.05; 95% confidence interval (95% CI), 1.17–42.21] and when DLOD (day 3−day 1 LOD score/day 3 LOD score) was high (OR, 3.47; 95% CI, 1.44–8.39); mortality was lower when admission occurred between 1998 and 2000 (OR, 0.23; 95% CI, 0.05–0.98) and when initial antibiotics were adapted (OR, 0.24; 95% CI, 0.06–0.09).

Conclusions

Earlier ICU admission and antibiotic treatment of critically ill cancer patients with septic shock is associated with higher 30-day survival. The LOD score change on day 3 as compared to admission is useful for predicting survival.
Literature
1.
Bodey GP (2000) Unusual presentations of infection in neutropenic patients. Int J Antimicrob Agents 16:93–95CrossRefPubMed
2.
Azoulay E, Recher C, Alberti C, Soufir L, Leleu G, Le Gall JR, Fermand JP, Schlemmer B (1999) Changing use of intensive care for hematological patients: the example of multiple myeloma. Intensive Care Med 25:1395–1401PubMed
3.
Azoulay E, Moreau D, Alberti C, Leleu G, Adrie C, Barboteu M, Cottu P, Levy V, Le Gall JR, Schlemmer B (2000) Predictors of short-term mortality in critically ill patients with solid malignancies. Intensive Care Med 26:1817–1823CrossRefPubMed
4.
Blot F, Guiguet M, Nitenberg G, Leclercq B, Gachot B, Escudier B (1997) Prognostic factors for neutropenic patients in an intensive care unit: respective roles of underlying malignancies and acute organ failures. Eur J Cancer 33:1031–1037PubMed
5.
Kress JP, Christenson J, Pohlman AS, Linkin DR, Hall JB (1999) Outcomes of critically ill cancer patients in a university hospital setting. Am J Respir Crit Care Med 160:1957–1961PubMed
6.
Staudinger T, Stoiser B, Mullner M, Locker GJ, Laczika K, Knapp S, Burgmann H, Wilfing A, Kofler J, Thalhammer F, Frass M (2000) Outcome and prognostic factors in critically ill cancer patients admitted to the intensive care unit. Crit Care Med 28:1322–1328PubMed
7.
Crawford SW, Schwartz DA, Petersen FB, Clark JG (1988) Mechanical ventilation after marrow transplantation. Risk factors and clinical outcome. Am Rev Respir Dis 137:682–687PubMed
8.
Epner DE, White P, Krasnoff M, Khanduja S, Kimball KT, Knaus WA (1996) Outcome of mechanical ventilation for adults with hematologic malignancy. J Investig Med 44:254–260PubMed
9.
Kongsgaard UE, Meidell NK (1999) Mechanical ventilation in critically ill cancer patients: outcome and utilisation of resources. Support Care Cancer 7:95–99CrossRef
10.
Azoulay E, Alberti C, Bornstain C, Leleu G, Moreau D, Recher C, Chevret S, Le Gall JR, Brochard L, Schlemmer B (2001) Improved survival in cancer patients requiring mechanical ventilatory support: impact of noninvasive mechanical ventilatory support. Crit Care Med 29:519–525PubMed
11.
Hilbert G, Gruson D, Vargas F, Valentino R, Gbikpi-Benissan G, Dupon M, Reiffers J, Cardinaud JP (2001) Noninvasive ventilation in immunosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure. N Engl J Med 344:481–487PubMed
12.
American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference (1992) American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864–874PubMed
13.
Alberti C, Brun-Buisson C, Burchardi H, Martin C, Goodman S, Artigas A, Sicignano A, Palazzo M, Moreno R, Boulme R, Lepage E, Le Gall R (2002) Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 28:108–121PubMed
14.
Knaus WA, Zimmerman JE, Wagner DP, Draper EA, Lawrence DE (1981) APACHE-acute physiology and chronic health evaluation: a physiologically based classification system. Crit Care Med 9:591–597PubMed
15.
Darmon M, Azoulay E, Alberti C, Fieux F, Moreau D, Gall JR, Schlemmer B (2002) Impact of neutropenia duration on short-term mortality in neutropenic critically ill cancer patients. Intensive Care Med 28:1775–1780CrossRefPubMed
16.
Gruson D, Hilbert G, Bebear C, Allery A, Boiron JM, Pigneux A, Vargas F, Reiffers J, Gbikpi-Benissan G, Cardinaud JP (1998) Early infectious complications after bone marrow transplantation requiring medical ICU admission. Hematol Cell Ther 40:269–274PubMed
17.
Le Gall JR, Lemeshow S, Saulnier F (1993) A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study. JAMA 270:2957–2963PubMed
18.
Le Gall JR, Klar J, Lemeshow S, Saulnier F, Alberti C, Artigas A, Teres D (1996) The Logistic Organ Dysfunction system. A new way to assess organ dysfunction in the intensive care unit. ICU Scoring Group. JAMA 276:802–810PubMed
19.
Timsit JF, Misset B, Azoulay E, Renaud B, Garrouste-Orgeas M, Carlet J (1996) Usefulness of airway visualization in the diagnosis of nosocomial pneumonia in ventilated patients. Chest 110:172–179PubMed
20.
Barnes RA, Stallard N (2001) Severe infections after bone marrow transplantation. Curr Opin Crit Care 7:362–366CrossRefPubMed
21.
Elting LS, Rubenstein EB, Rolston KV, Bodey GP (1997) Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials. Clin Infect Dis 25:247–259PubMed
22.
Uzun O, Ascioglu S, Anaissie EJ, Rex JH (2001) Risk factors and predictors of outcome in patients with cancer and breakthrough candidemia. Clin Infect Dis 32:1713–1717PubMed
23.
Anderson KC, Soiffer R, DeLage R, Takvorian T, Freedman AS, Rabinowe SL, Nadler LM, Dear K, Heflin L, Mauch P, et al. (1990) T-cell-depleted autologous bone marrow transplantation therapy: analysis of immune deficiency and late complications. Blood 76:235–244PubMed
24.
Campbell JH, Blessing N, Burnett AK, Stevenson RD (1993) Investigation and management of pulmonary infiltrates following bone marrow transplantation: an eight year review. Thorax 48:1248–1251PubMed
25.
Meletis J, Arlet G, Dournon E, Pol S, Devergie A, Sportes C, Peraldi MN, Mayaud C, Perol Y, Gluckman E (1987) Legionnaires' disease after bone marrow transplantation. Bone Marrow Transplant 2:307–313PubMed
26.
Khassawneh BY, White P, Jr., Anaissie EJ, Barlogie B, Hiller FC (2002) Outcome from mechanical ventilation after autologous peripheral blood stem cell transplantation. Chest 121:185–188CrossRefPubMed
27.
Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M, Early Goal-Directed Therapy Collaborative Group (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368–1377PubMed
28.
29.
Guiguet M, Blot F, Escudier B, Antoun S, Leclercq B, Nitenberg G (1998) Severity-of-illness scores for neutropenic cancer patients in an intensive care unit: which is the best predictor? Do multiple assessment times improve the predictive value? Crit Care Med 26:488–493PubMed
30.
Timsit JF, Fosse JP, Troche G, De Lassence A, Alberti C, Garrouste-Orgeas M, Azoulay E, Chevret S, Moine P, Cohen Y (2001) Accuracy of a composite score using daily SAPS II and LOD scores for predicting hospital mortality in ICU patients hospitalized for more than 72 h. Intensive Care Med 27:1012–1021PubMed
31.
Rubenfeld GD, Crawford SW (1996) Withdrawing life support from mechanically ventilated recipients of bone marrow transplants: a case for evidence-based guidelines. Ann Intern Med 125:625–633PubMed
32.
Natsch S, Kullberg BJ, Meis JF, van der Meer JW (2000) Earlier initiation of antibiotic treatment for severe infections after interventions to improve the organization and specific guidelines in the emergency department. Arch Intern Med 160:1317–1320CrossRefPubMed
33.
Natsch S, Kullberg BJ, van der Meer JW, Meis JF (1998) Delay in administering the first dose of antibiotics in patients admitted to hospital with serious infections. Eur J Clin Microbiol Infect Dis 17:681–684CrossRefPubMed
34.
Bernard GR, Vincent JL, Laterre PF, LaRosa SP, Dhainaut JF, Lopez-Rodriguez A, Steingrub JS, Garber GE, Helterbrand JD, Ely EW, Fisher CJ, Jr (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344:699–709PubMed
35.
Annane D, Sebille V, Charpentier C, Bollaert PE, Francois B, Korach JM, Capellier G, Cohen Y, Azoulay E, Troche G, Chaumet-Riffaut P, Bellissant E (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288:862–871PubMed
Metadata
Title
Improved survival of critically ill cancer patients with septic shock
Authors
Jérôme Larché
Élie Azoulay
Fabienne Fieux
Laurent Mesnard
Delphine Moreau
Guillaume Thiery
Michaël Darmon
Jean-Roger Le Gall
Benoît Schlemmer
Publication date
01-10-2003
Publisher
Springer-Verlag
Published in
Intensive Care Medicine / Issue 10/2003
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-003-1957-y

Other articles of this Issue 10/2003

Intensive Care Medicine 10/2003 Go to the issue

Neonatal and Pediatric Intensive Care

Endothelial nitric oxide synthase (NOS) is upregulated in rapid progressive pulmonary hypertension of the newborn

Editorial

Inhaled nitric oxide for ARDS: searching for a more focused use

Editorial

Is high frequency oscillation the best lung protective ventilatory approach for ARDS?

Original

High-frequency oscillatory ventilation in adult acute respiratory distress syndrome

Original

Head helmet versus face mask for non-invasive continuous positive airway pressure: a physiological study

Brief Report

Massive hemoptysis due to Rasmussen aneurysm: detection with helicoidal CT angiography and successful steel coil embolization